{"mainPropery":{"diseaseId":8622,"diseaseName":"Immunodeficiency with thymoma","hasGardWebPage":true,"isRare":true,"websiteUrl":"https://rarediseases.info.nih.gov/diseases/8622/immunodeficiency-with-thymoma","synonyms":["Thymoma-immunodeficiency syndrome","Good syndrome"],"synonyms-with-source":[{"name":"Thymoma-immunodeficiency syndrome","source":"Orphanet"},{"name":"Good syndrome","source":"Orphanet"}],"identifiers":[{"identifierType":"ORPHANET","identifierId":"169105"},{"identifierType":"UMLS","identifierId":"C0221027"}]},"diseaseCategories":[{"diseaseTypeId":13,"diseaseTypeName":"Immune System Diseases","source":"Orphanet"}],"organizations":[{"resourceID":151,"resourceName":"Jeffrey Modell Foundation","abbreviation":"JMF","address1":"780 Third Ave","address2":"","address3":"","address4":"","address5":"","city":"New York","state":"NY","zip":"10017","country":"United States","phone":"","tty":"","tollFree":"","fax":"212-764-4180","email":"info@jmfworld.org","url":"http://www.info4pi.org/","freeText":"JMF is a global patient organization devoted to early and precise diagnosis, meaningful treatments, and ultimately, cures - through clinical and basic research, physician education, patient support, advocacy, public awareness and newborn screening."},{"resourceID":152,"resourceName":"International Patient Organization for Primary Immunodeficiencies","abbreviation":"IPOPI","address1":"Rock Bottom, Trerieve","address2":"Downderry","address3":"PL11 3LY","address4":"","address5":"","city":"","state":"","zip":"","country":"United Kingdom","phone":"44-01503-250-668/961","tty":"","tollFree":"","fax":"","email":"Info@ipopi.org","url":"https://ipopi.org","freeText":""},{"resourceID":161,"resourceName":"Immune Deficiency Foundation","abbreviation":"","address1":"110 West Road, Suite 300","address2":"","address3":"","address4":"","address5":"","city":"Towson","state":"MD","zip":"21204","country":"United States","phone":"","tty":"","tollFree":"1-800-296-4433","fax":"+1-410-321-9165","email":"https://www.primaryimmune.org/services/ask-idf/","url":"https://www.primaryimmune.org/","freeText":""},{"resourceID":667,"resourceName":"Canadian Immunodeficiencies Patient Organization (CIPO)","abbreviation":"","address1":"25 La Grave St ","address2":"Winnepeg, MB","address3":"","address4":"","address5":"","city":"","state":"","zip":"R3V 1J1","country":"Canada","phone":"877-262-2476 (toll-free)","tty":"","tollFree":"","fax":"866-942-7651 (toll-free)","email":"http://www.cipo.ca/#contact","url":"http://cipo.ca","freeText":""},{"resourceID":875,"resourceName":"Immune Deficiencies Foundation Australia","abbreviation":"","address1":"PO Box 969","address2":"Penrith NSW 2751","address3":"","address4":"","address5":"","city":"","state":"","zip":"","country":"Australia","phone":"800-100-198","tty":"","tollFree":"","fax":"","email":"info@idfa.org.au","url":"http://www.idfa.org.au/"}],"resource descriptions":[{"id":8,"resourceId":11,"resourceName":"PubMed","descriptionText":"<a href='http://www.ncbi.nlm.nih.gov/pubmed?term=Good%20syndrome%20%5Bti%5D' target='_blank'>PubMed</a> is a searchable database of medical literature and lists journal articles that discuss Immunodeficiency with thymoma. Click on the link to view a sample search on this topic.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":9,"resourceId":12,"resourceName":"ClinicalTrials.gov","descriptionText":"<a href='http://clinicaltrials.gov/ct2/results?term=Immunodeficiency+with+thymoma' target='_blank'>ClinicalTrials.gov</a> lists trials that are related to Immunodeficiency with thymoma. Click on the link to go to ClinicalTrials.gov to read descriptions of these studies. <br />\r\n<br />\r\n<em><strong>Please note:</strong>&nbsp;Studies listed on the&nbsp;ClinicalTrials.gov&nbsp;website are listed for informational purposes only; being listed does not reflect an endorsement by GARD or the NIH. We strongly recommend that you talk with a trusted healthcare provider before choosing to participate in any clinical study.</em>","resourceClassificationName":"Research","resourceClassificationSectionName":"Clinical Research Resources"},{"id":1531,"resourceId":2162,"resourceName":"Medscape Reference","descriptionText":"<a href='http://emedicine.medscape.com/article/884942-overview' target='_blank'>Medscape Reference</a> provides information on this topic. You may need to register to view the medical textbook, but registration is free.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1534,"resourceId":2165,"resourceName":"Orphanet","descriptionText":"<a href='http://www.orpha.net/consor/cgi-bin/OC_Exp.php?lng=en&Expert=169105' target='_blank'>Orphanet</a> is a European reference portal for&nbsp;information on rare diseases and orphan drugs. Access to this database is free of charge.<br />\r\n","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":1575,"resourceId":2185,"resourceName":"National Institute of Allergy and Infectious Diseases","descriptionText":"The <a href='http://www.niaid.nih.gov' target='_blank'>National Institute of Allergy and Infectious Diseases</a> (NIAID) supports scientists developing better ways to diagnose, treat, and prevent the many infectious, immunologic, and allergic diseases that afflict people worldwide. You can contact NIAID for more information on this topic by calling 301-496-5717 or by visiting their Web site. ","resourceClassificationName":"Overview","resourceClassificationSectionName":"Where to Start"},{"id":2135,"resourceId":3342,"resourceName":"Monarch Initiative","descriptionText":"The <a href='https://monarchinitiative.org/disease/DOID:0060028' target='_blank'>Monarch Initiative</a> brings together data about this condition from humans and other species to help physicians and biomedical researchers. Monarch&rsquo;s tools are designed to make it easier to compare the signs and symptoms (phenotypes) of different diseases and discover common features. This initiative is a collaboration between several academic institutions across the world and is funded by the National Institutes of Health. Visit the website to explore the biology of this condition.","resourceClassificationName":"Overview","resourceClassificationSectionName":"In-Depth Information"},{"id":2722,"resourceId":4053,"resourceName":"Patient Registry","descriptionText":"A registry supports research by collecting of information about patients that share something in common, such as being diagnosed with Immunodeficiency with thymoma. The type of data collected can vary from registry to registry and is based on the goals and purpose of that registry. Some registries collect contact information while others collect more detailed medical information. <a href=\"https://www.nih.gov/health-information/nih-clinical-research-trials-you/list-registries\" target=\"_blank\">Learn more about registries</a>.<br />\r\n<br />\r\nRegistries for&nbsp;Immunodeficiency with thymoma:<br />\r\n<a href='https://usidnet.org/about-the-registry/patient-participation/' target='_blank'>United States Immunodeficiency Network (USIDENT) Registry</a><br />&nbsp;","resourceClassificationName":"Research","resourceClassificationSectionName":"Patient Registry"}],"overviewQuestion":{"questionId":5741,"questionText":"What is Good syndrome?","answerText":"<strong>Good syndrome </strong>is a rare, adult-onset primary immunodeficiency suspected in patients who exhibit <a href=\"http://emedicine.medscape.com/article/884942-overview\" target=_blank>hypogammaglobulinemia</a> and low levels of B cells along with a benign thymic tumor (thymoma) on chest X-ray.[4726][4727][4728] Symptoms include frequent opportunistic infections involving the sinuses and lungs, including severe <a href=\"http://www.nlm.nih.gov/medlineplus/cytomegalovirusinfections.html\" target=_blank>CMV disease</a>, <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000671.htm\" target=_blank>P. carinii pneumonia</a>, and <a href=\"http://www.nlm.nih.gov/medlineplus/ency/article/000880.htm\" target=_blank>mucocutaneous candidiasis</a>.[4727][4728] While the cause of Good syndrome remains unknown, there is some evidence that a defect of the bone marrow is involved.[4728] Treatment includes removal of the thymic tumor and <a href=\"http://www.nlm.nih.gov/medlineplus/druginfo/meds/a682815.html\" target=_blank>immunoglobulin replacement</a>.[4726][4727][4728]","dateModified":"2012-10-31T11:37:00"},"basicQuestions":[{"questionId":6513,"questionText":"What is the long-term outlook for people with Good syndrome?","answerText":"The long-term outlook (prognosis) for individuals with Good syndrome is believed to be worse than for those with other immunodeficiencies. The outlook is affected more by the severity of associated infections, hematologic complications, and autoimmune diseases, rather than by the behavior of the thymoma. In addition, the course of the condition may be more severe for individuals who require immunosuppressive drugs for associated autoimmune complications.<br><br>One single center review of individuals with <a href=\"http://www.ukpips.org.uk/faqs/primary-antibody-deficiency/\" target=_blank>primary antibody deficiency</a>, spanning 20 years, reported that 70% of individuals with Good syndrome were still living 5 years after the diagnosis. At 10 years, only 33% were still living. Another review of 152 cases found significant overall mortality (46%) associated with the condition.[5595]","dateModified":"2012-10-31T11:26:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5595,"authors":"Kelesidis T, Yang O","articleTitle":"Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence","bookWebsiteJournalTitle":"Clin Immunol","date":"June 2010","volume":"135(3)","pages":"347-363","url":"https://www.ncbi.nlm.nih.gov/pubmed/20149753","authors2":"","placeOfPublication":"","publisher":""}]}],"references":[],"relatedDiseases":[],"gardCases":[{"caseId":36959,"abbreviatedInquiry":"I would like to know the incidence of Good syndrome. I find very limited on-line information and have never encountered a doctor with another patient with this disease, or generally even a doctor who has heard of it. I wonder if there is any possibility of a support community. I would also like to know the prognosis for this disease and its impact on life expectancy.","caseQuestions":[{"questionId":6511,"questionText":"How many people have Good syndrome?","answerText":"Good syndrome occurs in individuals all over the world, although approximately half of the cases described in the literature have been in Europe.[5595] An article published in 2010 stated that as of that year, there were less than 60 reported cases of Good syndrome worldwide.[5604] Some other published statistics related to the occurrence of Good syndrome include the following:<br>\r\n<ul>\r\n<li>Good syndrome occurs in 3-6% of individuals with thymomas.[5603] \r\n<li>In the United States, the incidence of thymoma is approximately 0.15 cases per 100,000, and this tumor can be found in up to 10% of individuals with adult-onset hypogammaglobulinemia. On the other hand, the incidence of hypogammaglobulinemia is between 6–11% in individuals with thymoma.[5595] \r\n<li>It has been estimated that Good syndrome is the underlying cause of immunodeficiency in 1% to 2% of individuals with <a href=\"http://www.ukpips.org.uk/faqs/primary-antibody-deficiency/\" target=_blank>primary antibody deficiency</a> who are on immunoglobulin replacement treatments.[5595]</li></ul>","dateModified":"2012-10-31T11:29:00","references":[{"referenceId":5595,"authors":"Kelesidis T, Yang O","articleTitle":"Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence","bookWebsiteJournalTitle":"Clin Immunol","date":"June 2010","volume":"135(3)","pages":"347-363","url":"https://www.ncbi.nlm.nih.gov/pubmed/20149753","authors2":"","placeOfPublication":"","publisher":""},{"referenceId":5603,"authors":"Ogoshi T. et al","articleTitle":"A case of good syndrome with pulmonary lesions similar to diffuse panbronchiolitis","bookWebsiteJournalTitle":"Intern Med","date":"2012","volume":"51(9)","pages":"1087-1091"},{"referenceId":5604,"authors":"Ho JK, Wong MM, Tai TK, Tse DM","articleTitle":"A rare combination of recurrent pneumonia, diarrhoea, and visual loss in a patient after thymectomy: good syndrome","bookWebsiteJournalTitle":"Hong Kong Med J","date":"December 2010","volume":"16(6)","pages":"493-496"}]},{"questionId":6512,"questionText":"Are there any support resources for individuals with Good syndrome?","answerText":"We are unaware of organizations that provide services or supportive resources that focus exclusively on Good syndrome; however, we have identified several groups that focus on immunodeficiencies in general. To view this information on our Web site, <a href=\"http://rarediseases.info.nih.gov/GARD/Condition/8622/Good_syndrome.aspx/Panel1#Resources\" target=_blank>click here</a>.","dateModified":"2012-10-31T11:11:00","references":[]},{"questionId":6513,"questionText":"What is the long-term outlook for people with Good syndrome?","answerText":"The long-term outlook (prognosis) for individuals with Good syndrome is believed to be worse than for those with other immunodeficiencies. The outlook is affected more by the severity of associated infections, hematologic complications, and autoimmune diseases, rather than by the behavior of the thymoma. In addition, the course of the condition may be more severe for individuals who require immunosuppressive drugs for associated autoimmune complications.<br><br>One single center review of individuals with <a href=\"http://www.ukpips.org.uk/faqs/primary-antibody-deficiency/\" target=_blank>primary antibody deficiency</a>, spanning 20 years, reported that 70% of individuals with Good syndrome were still living 5 years after the diagnosis. At 10 years, only 33% were still living. Another review of 152 cases found significant overall mortality (46%) associated with the condition.[5595]","dateModified":"2012-10-31T11:26:00","resourceClassificationName":"Prognosis","references":[{"referenceId":5595,"authors":"Kelesidis T, Yang O","articleTitle":"Good's syndrome remains a mystery after 55 years: A systematic review of the scientific evidence","bookWebsiteJournalTitle":"Clin Immunol","date":"June 2010","volume":"135(3)","pages":"347-363","url":"https://www.ncbi.nlm.nih.gov/pubmed/20149753","authors2":"","placeOfPublication":"","publisher":""}]}]}],"news":[{"newsId":671,"dateCreated":"2020-05-20T13:39:00","publishDate":"2020-05-22T00:00:00","title":"NIH-Supported Research Survey to Examine Impact of COVID-19 on Rare Diseases Community","description":"The NIH-funded Rare Diseases Clinical Research Network (RDCRN) has launched an <a href=\"https://www.rarediseasesnetwork.org/COVIDsurvey \" target=\"_blank\">online research survey</a> to find out how the COVID-19 pandemic is impacting individuals with rare diseases, their families and their caregivers. Your participation can help the rare disease research community shed light on the needs of people with rare diseases during this and other potential health crises, in addition to informing future research efforts. The survey must be completed by December 15, 2020.","url":"https://www.rarediseasesnetwork.org/COVIDsurvey","lastModified":"2020-11-30T14:44:00","isFeatured":false}],"conferences":[],"phenoTypes":[{"phenoTypeId":3592,"phenoTypeName":"Decreased circulating antibody level","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11806,"phenoTypeName":"Mediastinal lymphadenopathy","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":11702,"phenoTypeName":"Thymoma","frequencyText":"Very frequent","percentRanges":"80%-99%"},{"phenoTypeId":15520,"phenoTypeName":"Abnormal leukocyte morphology","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13740,"phenoTypeName":"Bronchiectasis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9070,"phenoTypeName":"Cough","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13402,"phenoTypeName":"Dysphagia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4768,"phenoTypeName":"Dysphonia","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13726,"phenoTypeName":"Dyspnea","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":13593,"phenoTypeName":"Fatigable weakness","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":5615,"phenoTypeName":"Ptosis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":4739,"phenoTypeName":"Recurrent skin infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":6542,"phenoTypeName":"Recurrent urinary tract infections","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":9832,"phenoTypeName":"Sinusitis","frequencyText":"Frequent","percentRanges":"30%-79%"},{"phenoTypeId":15539,"phenoTypeName":"Anemia","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":11065,"phenoTypeName":"Aplasia/Hypoplasia of the thymus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":14182,"phenoTypeName":"Diabetes mellitus","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":13401,"phenoTypeName":"Diarrhea","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":8075,"phenoTypeName":"Recurrent respiratory infections","frequencyText":"Occasional","percentRanges":"5%-29%"},{"phenoTypeId":15512,"phenoTypeName":"Thrombocytopenia","frequencyText":"Occasional","percentRanges":"5%-29%"}],"medicalProducts":[],"EncodedName":"Immunodeficiency_with_thymoma"}